Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of T Cell Surface Glycoprotein CD4 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of T Cell Surface Glycoprotein CD4market, defines the market attractiveness level of T Cell Surface Glycoprotein CD4 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of T Cell Surface Glycoprotein CD4 industry, describes the types of T Cell Surface Glycoprotein CD4 market, the applications of major players and the market size, and deeply analyzes the current situation of the global T Cell Surface Glycoprotein CD4 market and the development prospects and opportunities of T Cell Surface Glycoprotein CD4 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global T Cell Surface Glycoprotein CD4 market in Chapter 13.
By Player:
CEL-SCI Corp
Sanofi
Immupharma Plc
Biotest AG
United Biomedical Inc
Fountain Biopharma Inc
TaiMed Biologics Inc
Bristol-Myers Squibb Co
By Type:
Forigerimod Acetate
HIV Vaccine 2
Ibalizumab
Others
By End-User:
HIV
AIDS
GVHD
SARS
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 T Cell Surface Glycoprotein CD4 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 T Cell Surface Glycoprotein CD4 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 T Cell Surface Glycoprotein CD4 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 T Cell Surface Glycoprotein CD4 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise T Cell Surface Glycoprotein CD4 Market Analysis and Outlook to 2022
-
7.1 Global T Cell Surface Glycoprotein CD4 Consumption (2017-2022)
-
7.2 United States T Cell Surface Glycoprotein CD4 Consumption (2017-2022)
-
7.3 Europe T Cell Surface Glycoprotein CD4 Consumption (2017-2022)
-
7.4 China T Cell Surface Glycoprotein CD4 Consumption (2017-2022)
-
7.5 Japan T Cell Surface Glycoprotein CD4 Consumption (2017-2022)
-
7.6 India T Cell Surface Glycoprotein CD4 Consumption (2017-2022)
-
7.7 South Korea T Cell Surface Glycoprotein CD4 Consumption (2017-2022)
8 Region and Country-wise T Cell Surface Glycoprotein CD4 Market Analysis and Outlook to 2028
-
8.1 Global T Cell Surface Glycoprotein CD4 Consumption Forecast (2022-2028)
-
8.2 United States T Cell Surface Glycoprotein CD4 Consumption Forecast (2022-2028)
-
8.3 Europe T Cell Surface Glycoprotein CD4 Consumption Forecast (2022-2028)
-
8.4 China T Cell Surface Glycoprotein CD4 Consumption Forecast (2022-2028)
-
8.5 Japan T Cell Surface Glycoprotein CD4 Consumption Forecast (2022-2028)
-
8.6 India T Cell Surface Glycoprotein CD4 Consumption Forecast (2022-2028)
-
8.7 South Korea T Cell Surface Glycoprotein CD4 Consumption Forecast (2022-2028)
9 Global T Cell Surface Glycoprotein CD4 Market Outlook by Types and Applications to 2022
-
9.1 Global T Cell Surface Glycoprotein CD4 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Forigerimod Acetate Consumption and Growth Rate (2017-2022)
-
9.1.2 Global HIV Vaccine 2 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Ibalizumab Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global T Cell Surface Glycoprotein CD4 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global HIV Consumption and Growth Rate (2017-2022)
-
9.2.2 Global AIDS Consumption and Growth Rate (2017-2022)
-
9.2.3 Global GVHD Consumption and Growth Rate (2017-2022)
-
9.2.4 Global SARS Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global T Cell Surface Glycoprotein CD4 Market Outlook by Types and Applications to 2028
-
10.1 Global T Cell Surface Glycoprotein CD4 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Forigerimod Acetate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global HIV Vaccine 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Ibalizumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global T Cell Surface Glycoprotein CD4 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global AIDS Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global GVHD Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global SARS Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global T Cell Surface Glycoprotein CD4 Import and Export Analysis (Top 5 Countries)
-
11.1 Global T Cell Surface Glycoprotein CD4 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global T Cell Surface Glycoprotein CD4 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 T Cell Surface Glycoprotein CD4 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global T Cell Surface Glycoprotein CD4 Market Competitive Analysis
-
14.1 CEL-SCI Corp
-
14.1.1 CEL-SCI Corp Company Details
-
14.1.2 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product and Service
-
14.2 Sanofi
-
14.2.1 Sanofi Company Details
-
14.2.2 Sanofi T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi T Cell Surface Glycoprotein CD4 Product and Service
-
14.3 Immupharma Plc
-
14.3.1 Immupharma Plc Company Details
-
14.3.2 Immupharma Plc T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Immupharma Plc T Cell Surface Glycoprotein CD4 Product and Service
-
14.4 Biotest AG
-
14.4.1 Biotest AG Company Details
-
14.4.2 Biotest AG T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biotest AG T Cell Surface Glycoprotein CD4 Product and Service
-
14.5 United Biomedical Inc
-
14.5.1 United Biomedical Inc Company Details
-
14.5.2 United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 United Biomedical Inc T Cell Surface Glycoprotein CD4 Product and Service
-
14.6 Fountain Biopharma Inc
-
14.6.1 Fountain Biopharma Inc Company Details
-
14.6.2 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product and Service
-
14.7 TaiMed Biologics Inc
-
14.7.1 TaiMed Biologics Inc Company Details
-
14.7.2 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product and Service
-
14.8 Bristol-Myers Squibb Co
-
14.8.1 Bristol-Myers Squibb Co Company Details
-
14.8.2 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of T Cell Surface Glycoprotein CD4
-
Figure T Cell Surface Glycoprotein CD4 Picture
-
Table Global T Cell Surface Glycoprotein CD4 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global T Cell Surface Glycoprotein CD4 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global T Cell Surface Glycoprotein CD4 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global T Cell Surface Glycoprotein CD4 Consumption by Country (2017-2022)
-
Figure United States T Cell Surface Glycoprotein CD4 Consumption and Growth Rate (2017-2022)
-
Table Europe T Cell Surface Glycoprotein CD4 Consumption and Growth Rate (2017-2022)
-
Figure China T Cell Surface Glycoprotein CD4 Consumption and Growth Rate (2017-2022)
-
Figure Japan T Cell Surface Glycoprotein CD4 Consumption and Growth Rate (2017-2022)
-
Figure India T Cell Surface Glycoprotein CD4 Consumption and Growth Rate (2017-2022)
-
Figure South Korea T Cell Surface Glycoprotein CD4 Consumption and Growth Rate (2017-2022)
-
Figure Global T Cell Surface Glycoprotein CD4 Consumption Forecast by Country (2022-2028)
-
Figure United States T Cell Surface Glycoprotein CD4 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe T Cell Surface Glycoprotein CD4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China T Cell Surface Glycoprotein CD4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan T Cell Surface Glycoprotein CD4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India T Cell Surface Glycoprotein CD4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea T Cell Surface Glycoprotein CD4 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Forigerimod Acetate Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Vaccine 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Ibalizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global HIV Consumption and Growth Rate (2017-2022)
-
Figure Global AIDS Consumption and Growth Rate (2017-2022)
-
Figure Global GVHD Consumption and Growth Rate (2017-2022)
-
Figure Global SARS Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Forigerimod Acetate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HIV Vaccine 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ibalizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HIV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AIDS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GVHD Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global SARS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global T Cell Surface Glycoprotein CD4 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global T Cell Surface Glycoprotein CD4 Export by Region (Top 5 Countries) (2017-2028)
-
Table CEL-SCI Corp (Foundation Year, Company Profile and etc.)
-
Table CEL-SCI Corp T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table CEL-SCI Corp T Cell Surface Glycoprotein CD4 Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi T Cell Surface Glycoprotein CD4 Product and Service
-
Table Immupharma Plc (Foundation Year, Company Profile and etc.)
-
Table Immupharma Plc T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immupharma Plc T Cell Surface Glycoprotein CD4 Product and Service
-
Table Biotest AG (Foundation Year, Company Profile and etc.)
-
Table Biotest AG T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotest AG T Cell Surface Glycoprotein CD4 Product and Service
-
Table United Biomedical Inc (Foundation Year, Company Profile and etc.)
-
Table United Biomedical Inc T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table United Biomedical Inc T Cell Surface Glycoprotein CD4 Product and Service
-
Table Fountain Biopharma Inc (Foundation Year, Company Profile and etc.)
-
Table Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fountain Biopharma Inc T Cell Surface Glycoprotein CD4 Product and Service
-
Table TaiMed Biologics Inc (Foundation Year, Company Profile and etc.)
-
Table TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table TaiMed Biologics Inc T Cell Surface Glycoprotein CD4 Product and Service
-
Table Bristol-Myers Squibb Co (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Co T Cell Surface Glycoprotein CD4 Product and Service
-
